Description générale
INN
Vancomycin
Type de médicament
Chemical agent
Groupes d'antibiotiques
Historique des statuts LME
Ajouté pour la première fois en 1995
(TRS
867)
pour
Methicillin resistant Staphylococcus aureus
Ajouté en 2017
(TRS
1006)
pour
Neutropenia
Ajouté en 2017
(TRS
1006)
pour
Intestinal infections due to Clostridioides difficile
Retiré en 2017
(TRS
1006)
pour
Methicillin resistant Staphylococcus aureus
Ajouté en 2021
(TRS
1035)
pour
Necrotising fasciitis
Ajouté en 2023
(TRS
1049)
pour
Endophthalmitis
Wikipédia
DrugBank
Recommandations
Section
Watch group antibiotics
- Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
- Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
- Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
- Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection